Evolus Accelerates Next Phase of U.S. Launch of Jeuveau™ with ‘#NEWTOX NOW’ Consumer Conversion Program

by NASDAQ Market News June 5, 2019

NASDAQ Market News
Click here to email author

Dermavant Sciences Announces First Patient Dosed in PSOARING, its Pivotal Phase 3 Clinical Program for Tapinarof for the Topical Treatment of Plaque Psoriasis

Media Advisory/TODAY: Montreal’s Four Leading Pediatric Institutions to Announce Largest Collaboration in Canadian History to Help Children with Musculoskeletal Disorders

Ads